Scoggins B A, Maguire K P, Norman T R, Burrows G D
Clin Chem. 1980 Jun;26(7):805-15.
This review, together with Part 1 (Clin. Chem. 26: 5-17, 1980), summarizes progress in measurement of tricyclic antidepressants in biological fluids and the application of the methodology to clinical practice. For many of the older drugs and for all of the new-generation antidepressants, further studies are required to delineate the precise relationship between plasma concentration and clinical response in well-defined diagnostic groups. For new drugs, rigorous evaluation of a method of measurement is required before it is applied to clinical studies. Assessment of drug interactions, inter-patient variability in plasma concentrations, and determination of the plasma concentrations required for therapeutic response all depend almost entirely on the quality of the assay methodology.
本综述与第1部分(《临床化学》26: 5 - 17, 1980)一起,总结了生物体液中三环类抗抑郁药测量的进展以及该方法在临床实践中的应用。对于许多较老的药物以及所有新一代抗抑郁药,需要进一步研究以明确在明确诊断的群体中血浆浓度与临床反应之间的确切关系。对于新药,在将测量方法应用于临床研究之前,需要对其进行严格评估。药物相互作用的评估、患者间血浆浓度的变异性以及治疗反应所需血浆浓度的测定几乎完全取决于检测方法的质量。